Journal of Clinical Pharmacy and Therapeutics 2003-02-01

Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.

A S W Boutilier, D M Gardner

Index: J. Clin. Pharm. Ther. 28(1) , 69-72, (2003)

Full Text: HTML

Abstract

Structure	Name/CAS No.	Molecular Formula	Articles
	Zolmitriptan CAS:139264-17-8	C₁₆H₂₁N₃O₂

Bioenhanced sublingual tablet of drug with limited permeabil...
2015-08-01
[Eur. J. Pharm. Biopharm. 94 , 386-92, (2015)]

Zolmitriptan: a novel portal hypotensive agent which synergi...
2013-01-01
[PLoS ONE 8(1) , e52683, (2013)]

Preparation and evaluation of zolmitriptan submicron emulsio...
2011-12-01
[Drug Dev. Ind. Pharm. 37(12) , 1509-16, (2011)]

Evaluation of submicron emulsion as vehicles for rapid-onset...
2011-11-01
[Drug Deliv. 18(8) , 578-85, (2011)]

Quantitative determination of zolmitriptan in rat blood and ...
2012-07-15
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 901 , 72-8, (2012)]

Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.

Abstract

Related Compounds